0001209191-23-010248.txt : 20230216 0001209191-23-010248.hdr.sgml : 20230216 20230216182353 ACCESSION NUMBER: 0001209191-23-010248 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230214 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paolillo Leonard CENTRAL INDEX KEY: 0001852828 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40353 FILM NUMBER: 23639769 MAIL ADDRESS: STREET 1: C/O IMPEL NEUROPHARMA, INC. STREET 2: 201 ELLIOTT AVE. W, ST. 260 CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMPEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001445499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 0426 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 FORMER COMPANY: FORMER CONFORMED NAME: IMPEL NEUROPHARMA INC DATE OF NAME CHANGE: 20080917 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-14 0 0001445499 IMPEL PHARMACEUTICALS INC IMPL 0001852828 Paolillo Leonard C/O IMPEL NEUROPHARMA, INC. 201 ELLIOTT AVE. W, ST. 260 SEATTLE WA 98119 0 1 0 0 Chief Commercial Officer Stock Option (right to buy) 2.29 2023-02-14 4 A 0 50000 0.00 A 2033-02-13 Common Stock 50000 50000 D The option vests as to 2.0833% of the total shares on March 14, 2023 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on February 14, 2027, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ John Leaman, M.D. as attorney-in-fact 2023-02-16